Nyrada
Menu
NYR:
Market Cap*:
Price Delay ~20min
Home
About Us
Company Overview
Board of Directors
Management
Scientific Advisory Board
Corporate Governance
Our Science
Lead Drug Development
Brain Injury Program
Cholesterol Lowering Program
Technical Glossary
Drug Development Pathway
Investors
Investor Welcome
ASX Announcements
Brain Injury Program
Cholesterol-Lowering Program
Financial Reports
Corporate Announcements
Investor Presentations
Share Price Information
Key Dates
Investors Glossary
Annual Reports
Analyst Reports
Annual General Meeting
Extraordinary General Meeting
Past Shareholder Meetings
News & Insights
Presentations & Interviews
Media
Newsletters
Publications
Contact Us
Contact Us
Working at Nyrada
Email Alerts
Investors
Home
>
Investors
>
ASX Announcements
>
Corporate Announcements
Investor Welcome
ASX Announcements
Brain Injury Program
Cholesterol-Lowering Program
Financial Reports
Corporate Announcements
Investor Presentations
Share Price Information
Key Dates
Investors Glossary
Annual Reports
Analyst Reports
Annual General Meeting
Extraordinary General Meeting
Past Shareholder Meetings
Corporate Announcements
Filter by Year:
2024
2023
2022
2021
2020
22-Mar-2021
Nyrada Receives Firm Commitments to Raise A$11 Million
17-Mar-2021
Trading Halt
5-Mar-2021
Change of Director's Interest Notice - JM
2-Mar-2021
Nyrada Newsletter February 2021
24-Feb-2021
Appendix 3G
24-Feb-2021
Change of Director's Interest Notice - MF
16-Feb-2021
Lapsing of balance of Unlisted SAB Options
16-Feb-2021
Cleansing Statement
16-Feb-2021
Appendix 2A
29-Jan-2021
Trading Halt
Previous
1
2
3
4
5
Next
